Home › Parkinson's Disease › Washington
Parkinson's Disease clinical trials in Washington
15 studies for Parkinson's Disease are looking for participants at sites in Washington.
Cities in Washington
SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
- Inland Northwest Research, Spokane
RecruitingPhase 1
Ages 40 to 80 · All sexes · Updated Nov 12, 2026 · NCT07422675Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Evergreen Health, Kirkland
- Virginia Mason Medical Center, Seattle
- University of Washington Medical Center, Seattle
- and 1 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT02071134A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #023, Kirkland
- Vima Site #015, Spokane
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Nov 10, 2026 · NCT07804615A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- EvergreenHealth - Research Department, Kirkland
RecruitingPhase 3
Ages 45 to 75 · All sexes · Updated Nov 2, 2026 · NCT06944522A Study of Buntanetap in Participants With PD
- Inland Northwest Research, Spokane
RecruitingPhase 2/3
Ages 40 to 85 · All sexes · Updated Oct 30, 2026 · NCT07284784A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- EvergreenHealth, Kirkland
- Inland Northwest Research, Spokane
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Oct 30, 2026 · NCT06680830A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- EvergreenHealth (Site #219), Kirkland
RecruitingPhase 2
Ages 30 to 80 · All sexes · Updated Oct 28, 2026 · NCT07432958A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-007, Bellevue
- Site-019, Seattle
RecruitingPhase 2/3
Ages 40 to 80 · All sexes · Updated Oct 22, 2026 · NCT06976268A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
- Evergreen Health Research, Kirkland
- Inland Northwest Research, Spokane
RecruitingPhase 1Healthy volunteers welcome
Ages 30 to 85 · All sexes · Updated Oct 14, 2026 · NCT06809400Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- Inland Northwest Research, Spokane
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Sep 21, 2026 · NCT07005180Parkinson's Foundation PD GENEration Genetic Registry
- Evergreen Health, Kirkland
- Inland Northwest Research, Spokane
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT04994015A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- VA Puget Sound Health Care System, Seattle
RecruitingObservational study
Ages 45 to 75 · All sexes · Updated Sep 4, 2026 · NCT07330258PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Univ of Washington and VA Puget Sound Health Care System, Seattle
RecruitingObservational studyHealthy volunteers welcome
Ages 30 and older · All sexes · Updated Jul 27, 2026 · NCT04477785Use of CereGate Therapy for Freezing of Gait in PD
- University of Washington, Seattle
Recruiting
Ages 21 to 80 · All sexes · Updated May 28, 2026 · NCT05292794Modifiable Variables in Parkinsonism (MVP)
- Bastyr University, Kenmore
RecruitingObservational study
Ages 19 and older · All sexes · Updated Mar 25, 2022 · NCT02194816From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.